BIOAVAILABILITY OF BUMETANIDE IN GROSSLY EDEMATOUS PATIENTS

被引:12
作者
BAILIE, GR
GRENNAN, A
WALDEK, S
机构
[1] UNIV MANCHESTER,HOPE HOSP,DEPT CHEM PATHOL,SALFORD M6 8HD,LANCS,ENGLAND
[2] UNIV MANCHESTER,HOPE HOSP,RENAL UNIT,SALFORD M6 8HD,LANCS,ENGLAND
关键词
D O I
10.2165/00003088-198712060-00004
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
引用
收藏
页码:440 / 443
页数:4
相关论文
共 8 条
[1]
CANTON AD, 1985, KIDNEY INT, V28, pS154
[2]
HONARI J, 1977, CLIN PHARMACOL THER, V22, P395
[3]
THE PHARMACOKINETICS AND PHARMACODYNAMICS OF THE DIURETIC BUMETANIDE IN HEPATIC AND RENAL-DISEASE [J].
MARCANTONIO, LA ;
AULD, WHR ;
MURDOCH, WR ;
PUROHIT, R ;
SKELLERN, GG ;
HOWES, CA .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (02) :245-252
[4]
THE PHARMACOKINETICS AND PHARMACODYNAMICS OF BUMETANIDE IN NORMAL SUBJECTS [J].
MARCANTONIO, LA ;
AULD, WHR ;
SKELLERN, GG ;
HOWES, CA ;
MURDOCH, WR ;
PUROHIT, R .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1982, 10 (04) :393-409
[5]
DETERMINATION OF THE DIURETIC BUMETANIDE IN BIOLOGICAL-FLUIDS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
MARCANTONIO, LA ;
AULD, WHR ;
SKELLERN, GG .
JOURNAL OF CHROMATOGRAPHY, 1980, 183 (01) :118-123
[6]
NOTARI RE, 1980, BIOPHARMACEUTICS CLI
[7]
RENAL TUBULAR SECRETION AND EFFECTS OF FUROSEMIDE [J].
ODLIND, B ;
BEERMANN, B .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (06) :784-790
[8]
DIURETIC RESISTANCE - REDUCED BIOAVAILABILITY AND EFFECT OF ORAL FRUSEMIDE [J].
ODLIND, BG ;
BEERMANN, B .
BRITISH MEDICAL JOURNAL, 1980, 280 (6231) :1577-1577